نتایج جستجو برای: salvage chemotherapy

تعداد نتایج: 125989  

2017
Shigetaka Suekane Kousuke Ueda Kiyoaki Nishihara Tetsuro Sasada Takuto Yamashita Noriko Koga Shigeru Yutani Shigeki Shichijo Kyogo Itoh Tsukasa Igawa Masanori Noguchi

This study investigated the applicability of personalized peptide vaccination (PPV) for patients with metastatic upper tract urothelial cancer (mUTUC) after failure of platinum-based chemotherapy. In this single arm, open-label, phase II clinical trial, patients with mUTUC received PPV at a single institution. Personalized peptide vaccination treatment used a maximum of four peptides chosen fro...

2017
Qi Lai Conglin Ye Tian Gao Jun Xiao An Xie Xuqiang Liu Xiaolong Yu Jun Liu Min Dai Hucheng Liu Bin Zhang

RATIONALE Osteosarcoma is the most common malignant bone tumor in children and adolescents. Metastasis occurs early, the mortality rate is high, and the tumor results in a tremendous physical, mental, and economic burden on patients. Therefore, the treatment of osteosarcoma has been important for orthopedic surgeons. However, treatment has always been a difficult problem globally. PATIENT CON...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2005
J-L Pico G Rosti A Kramar H Wandt V Koza R Salvioni C Theodore G Lelli W Siegert A Horwich M Marangolo W Linkesch G Pizzocaro H-J Schmoll J Bouzy J-P Droz P Biron

BACKGROUND Incomplete remission or relapse from first-line chemotherapy has poor prognosis in male germ cell tumour patients. This phase III randomised trial compares conventional salvage to high-dose-intensification chemotherapy. PATIENTS AND METHODS Between February 1994 and September 2001, 280 patients from 43 institutions in 11 countries, were randomly assigned to receive either four cycl...

2015
Luca Castagna Carmelo Carlo-Stella Rita Mazza Armando Santoro

Classical Hodgkin lymphoma (cHL) is a relatively rare disease, with approximately 9,200 estimated new cases and 1,200 estimated deaths per year in the United States. First-line chemo-radiotherapy leads to cure rates approaching 80% in patients with advanced-stage disease. However, 25 to 30% of these patients are not cured with chemotherapy alone (i.e., the ABVD regimen) and show either primary ...

Journal: :Current pharmaceutical design 2012
Stefaan Mulier Jean-Pierre Claes Vincent Dierieck Jean-Olivier Amiel Jean-Philippe Pahaut Luc Marcelis Fabienne Bastin Denis Vanderbeeken Claude Finet Sophie Cran Thierry Velu

The standard treatment for advanced ovarian cancer consists in complete cytoreductive surgery (CRS) and intravenous combination chemotherapy with a platinum compound and a taxane. Although response rates to initial therapy are high, many patients will recur and die of peritoneal carcinomatosis. The addition of Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) to the standard therapy aims at inc...

Journal: :Chest 1997
T Jeanfaivre E Tuchais

etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European The experience of Drs. Musi, Di Vito, and Rosti with salvage chemotherapy for recurrent thymoma using a platinum-based regimen reiterates the observations we reported previously1 and raises new issues on the choice of therapy for recurrences after a second remission. A prolonged disea...

Journal: :Blood 2011
John Kuruvilla Armand Keating Michael Crump

Relapsed or refractory Hodgkin lymphoma is a challenging problem for clinicians who treat hematologic malignancies. The standard management of these patients should include the use of salvage chemotherapy followed by autologous stem cell transplant (ASCT) in patients who are chemotherapy sensitive. Open issues in this area include the role of functional imaging, the specific chemotherapy regime...

2011
John Kuruvilla Armand Keating Michael Crump

Relapsed or refractory Hodgkin lymphoma is a challenging problem for clinicians who treat hematologic malignancies. The standard management of these patients should include the use of salvage chemotherapy followed by autologous stem cell transplant (ASCT) in patients who are chemotherapy sensitive. Open issues in this area include the role of functional imaging, the specific chemotherapy regime...

2017
Jie Liu Ye Zhang Zhengjiang Li Shaoyan Liu Huizheng Li Zhengang Xu

BACKGROUND The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. METHODS We retrospectively reviewed 66 patients with previously irradiated recurrent T4...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید